Chart-Typ:
Zeitraum:
| STMicroelectronics International NV: STMicroelectronics future-proofs the development of next-gen cars with innovative memory solution for automotive microcontrollers | STMicroelectronics future-proofs the development of next-gen carswith innovative memory solution for automotive microcontrollers New Stellar microcontrollers with xMemory enable simpler, more scalable... ► Artikel lesen |
| JPMORGAN stuft STMicro auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für STMicroelectronics auf "Neutral" mit einem Kursziel von 29 Euro belassen. Je länger die Ungewissheit in puncto Zölle andauere... ► Artikel lesen |
| ROUNDUP/Aktien Europa Schluss: Erholung - Zollpolitik bleibt im Fokus | PARIS/LONDON/ZÜRICH (dpa-AFX) - In der Hoffnung auf Entspannung in den internationalen Zollstreitigkeiten sind die Anleger am Montag wieder stärker ins Risiko gegangen. Auf die überraschend für 90... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Business Update | SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
| Organovo Sells FXR Program To Eli Lilly | INDIANAPOLIS (dpa-AFX) - Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights | Significant progress toward submitting a biologics license application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen |
| Inovio Pharmaceuticals Inc. Q4 Income Declines | WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) released a profit for fourth quarter that decreased from last yearThe company's bottom line came in at $19.4 million, or $0.65 per share.... ► Artikel lesen |
| INOVIO Announces Promising Interim Results From Phase 1 Proof-of-Concept Trial Of DMAbs For COVID-19 | LONDON (dpa-AFX) - INOVIO (INO) announced promising interim results from an ongoing Phase 1 proof-of-concept trial evaluating DNA-Encoded Monoclonal Antibodies or DMAbs for COVID-19.In the trial... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STARDUST POWER INC finden Sie auf Wallstreet Online.
